Secondary retensioning of a tether-based device for transapical transcatheter mitral valve implantation.
Martin BeyerDavid MullerFederico De MarcoVinay BadhwarJean-Francois ObadiaFabien PrazThomas ModinePim ToninoGry DahleAlfredo CerilloSebastian LudwigLenard ConradiPublished in: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery (2024)
This multicentre study demonstrates technical feasibility, procedural safety and acute efficacy of retensioning procedures in the majority of patients. The potential to retension the tether in transapical TMVI may provide additional management advantages in populations at high surgical risk.
Keyphrases
- mitral valve
- end stage renal disease
- transcatheter aortic valve replacement
- transcatheter aortic valve implantation
- left atrial
- ejection fraction
- newly diagnosed
- left ventricular
- chronic kidney disease
- prognostic factors
- liver failure
- heart failure
- drug induced
- atrial fibrillation
- risk assessment
- aortic stenosis
- genetic diversity
- aortic dissection
- hepatitis b virus